CreativeOne Wealth LLC Buys 1,512 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

CreativeOne Wealth LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.6% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 11,903 shares of the healthcare conglomerate’s stock after purchasing an additional 1,512 shares during the quarter. CreativeOne Wealth LLC’s holdings in UnitedHealth Group were worth $6,959,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth $27,000. Macroview Investment Management LLC lifted its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth about $31,000. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC grew its holdings in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $608.54 on Wednesday. The firm’s 50-day simple moving average is $583.53 and its two-hundred day simple moving average is $554.65. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $560.03 billion, a PE ratio of 39.50, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UNH. Royal Bank of Canada cut their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Stephens reduced their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.